KR20000056981A - 위염, 웨궤양, 십이지장궤양 예방 및 치료를 위한 식품 - Google Patents
위염, 웨궤양, 십이지장궤양 예방 및 치료를 위한 식품 Download PDFInfo
- Publication number
- KR20000056981A KR20000056981A KR1019990040387A KR19990040387A KR20000056981A KR 20000056981 A KR20000056981 A KR 20000056981A KR 1019990040387 A KR1019990040387 A KR 1019990040387A KR 19990040387 A KR19990040387 A KR 19990040387A KR 20000056981 A KR20000056981 A KR 20000056981A
- Authority
- KR
- South Korea
- Prior art keywords
- food
- antibody
- ulcer
- gastritis
- gastric
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 43
- 208000007107 Stomach Ulcer Diseases 0.000 title claims abstract description 32
- 208000000718 duodenal ulcer Diseases 0.000 title claims abstract description 30
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 27
- 230000002496 gastric effect Effects 0.000 title claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 64
- 241000590002 Helicobacter pylori Species 0.000 claims abstract description 47
- 229940037467 helicobacter pylori Drugs 0.000 claims abstract description 46
- 241000894006 Bacteria Species 0.000 claims abstract description 36
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 32
- 239000004310 lactic acid Substances 0.000 claims abstract description 32
- 201000005917 gastric ulcer Diseases 0.000 claims abstract description 31
- 239000000427 antigen Substances 0.000 claims abstract description 28
- 102000036639 antigens Human genes 0.000 claims abstract description 28
- 108091007433 antigens Proteins 0.000 claims abstract description 28
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 19
- 230000002265 prevention Effects 0.000 claims abstract description 19
- 241000178948 Lactococcus sp. Species 0.000 claims abstract description 12
- 244000199866 Lactobacillus casei Species 0.000 claims abstract description 10
- 235000013958 Lactobacillus casei Nutrition 0.000 claims abstract description 10
- 229940017800 lactobacillus casei Drugs 0.000 claims abstract description 10
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 9
- 210000002969 egg yolk Anatomy 0.000 claims description 35
- 235000015140 cultured milk Nutrition 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 29
- 235000013345 egg yolk Nutrition 0.000 claims description 27
- 102000002322 Egg Proteins Human genes 0.000 claims description 26
- 108010000912 Egg Proteins Proteins 0.000 claims description 26
- 235000013601 eggs Nutrition 0.000 claims description 22
- 238000011282 treatment Methods 0.000 claims description 20
- 108010046334 Urease Proteins 0.000 claims description 16
- 230000007923 virulence factor Effects 0.000 claims description 13
- 239000000304 virulence factor Substances 0.000 claims description 13
- 101710116435 Outer membrane protein Proteins 0.000 claims description 9
- 210000003495 flagella Anatomy 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 239000003547 immunosorbent Substances 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 5
- 238000010790 dilution Methods 0.000 claims description 5
- 239000012895 dilution Substances 0.000 claims description 5
- 241000287828 Gallus gallus Species 0.000 claims description 4
- 235000013330 chicken meat Nutrition 0.000 claims description 4
- 210000001198 duodenum Anatomy 0.000 claims description 4
- 239000003223 protective agent Substances 0.000 claims description 4
- 108010017384 Blood Proteins Proteins 0.000 claims description 3
- 102000004506 Blood Proteins Human genes 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 208000025865 Ulcer Diseases 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- 235000015243 ice cream Nutrition 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 238000004448 titration Methods 0.000 claims description 3
- 231100000397 ulcer Toxicity 0.000 claims description 3
- 208000018522 Gastrointestinal disease Diseases 0.000 claims description 2
- 235000008452 baby food Nutrition 0.000 claims description 2
- 235000008429 bread Nutrition 0.000 claims description 2
- 235000014121 butter Nutrition 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 230000002183 duodenal effect Effects 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 235000013350 formula milk Nutrition 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 235000013310 margarine Nutrition 0.000 claims description 2
- 239000003264 margarine Substances 0.000 claims description 2
- 238000001356 surgical procedure Methods 0.000 claims description 2
- 241001655328 Bifidobacteriales Species 0.000 claims 1
- 208000005577 Gastroenteritis Diseases 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 10
- 230000000754 repressing effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 44
- 241000589989 Helicobacter Species 0.000 description 24
- 239000002671 adjuvant Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 238000002649 immunization Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 5
- 239000000679 carrageenan Substances 0.000 description 5
- 229920001525 carrageenan Polymers 0.000 description 5
- 229940113118 carrageenan Drugs 0.000 description 5
- 235000010418 carrageenan Nutrition 0.000 description 5
- 239000013592 cell lysate Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 235000012041 food component Nutrition 0.000 description 4
- 239000005417 food ingredient Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000008520 organization Effects 0.000 description 4
- 230000003449 preventive effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000589562 Brucella Species 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000027119 gastric acid secretion Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- NDZLIAZRGGTCJZ-UHFFFAOYSA-N 1h-indole;phenol Chemical compound OC1=CC=CC=C1.C1=CC=C2NC=CC2=C1 NDZLIAZRGGTCJZ-UHFFFAOYSA-N 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001473949 Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504 Species 0.000 description 1
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241001025070 Philophyllum Species 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000011166 aliquoting Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L15/00—Egg products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1232—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt in powdered, granulated or dried solid form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
면역 후의 주 | 항체 응집가 | 효소면역흡착법 항체역가 | ||
시료 A (균체파쇄액) | 시료 B(외막단백질+유레아제+편모) | 시료 A (균체 파쇄액) | 시료 B(외막단백질+유레아제+편모) | |
0 | 〈 20 | 〈20 | 200 | 200 |
1 | 40 | 40 | 200 | 200 |
2 | 40 | 80 | 400 | 400 |
3 | 80 | 160 | 800 | 800 |
4 | 160 | 320 | 1600 | 1600 |
6 | 320 | 640 | 3200 | 3200 |
8 | 640 | 1280 | 3200 | 6400 |
10 | 640 | 1280 | 6400 | 12800 |
12 | 640 | 1280 | 12800 | 12800 |
14 | 320 | 640 | 6400 | 6400 |
항체 역가(효소면역 흡착법) | |||||
보호제(%) | pH | 온도(pH 7) | |||
2 | 4 | 6 | 〈65℃ | 〉80℃ | |
0 | 3200 | 6400 | 12800 | 12800 | 3200 |
10 | 6400 | 12800 | 12800 | 12800 | 6400 |
20 | 3200 | 3200 | 6400 | 6400 | 3200 |
30 | 1600 | 3200 | 6400 | 6400 | 3200 |
면역 주 | 항체응집가 | 효소면역 흡착법 항체역가 | ||
비교예(프로인트 아주반트) | 실시예 2(본 발명의 아주반트) | 비교예(프로인트 아주반트) | 실시예 2(본 발명의 아주반트) | |
0 | 10 | 20 | 100 | 100 |
1 | 20 | 40 | 200 | 400 |
2 | 20 | 80 | 200 | 800 |
3 | 40 | 160 | 400 | 800 |
4 | 80 | 320 | 400 | 1600 |
6 | 160 | 640 | 800 | 3200 |
8 | 320 | 1280 | 800 | 3200 |
10 | 640 | 1280 | 1600 | 6400 |
12 | 640 | 1280 | 3200 | 6400 |
14 | 320 | 640 | 1600 | 3200 |
시료 | 잔존균수(%) |
시료 a | 10 |
시료 b | 90 |
대조군 | 100 |
성분 | 함량(%) |
원유 | 74 |
탈지분유 | 3 |
과즙 | 10 |
액상과당 | 3 |
함수결정포도당 | 4 |
고과당 | 2 |
난황액 | 1-2 |
정제수 | 2-3 |
계 | 100 |
Claims (13)
- 헬리코박터 필로리의 병독인자인 편모, 유레아제 및 외막단백질을 분리하여, 이 분리된 병독인자를 항원으로 하여 면역한 닭이 생산하는 난황을 포함하고 있는 계란으로부터 얻어지는 것을 특징으로 하는 항HP항체를 유효성분으로 함유하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 헬리코박터 필로리에 대해 억제능을 나타내는 락토코커스 sp. HY 49, 락토바실러스 카제이 HY 2782 및 비피도박테리아 롱검 HY 8001을 각각 단독으로 또는 혼합하여 유효성분으로 함유하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 항HP항체와 헬리코박터 필로리에 대해 억제능을 나타내는 유산균을 함께 유효성분으로 함유하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품으로서,상기 항HP항체는 헬리코박터 필로리의 병독인자인 편모, 유레아제 및 외막단백질을 분리하여 이를 항원으로 하여 면역한 닭이 생산하는 난황을 포함하고 있는 계란으로부터 얻어진 것이며;상기 유산균은 헬리코박터 필로리에 대해 억제능을 나타내는 락토코커스 sp. HY 49, 락토바실러스 카제이 HY 2782 및 비피도박테리아 롱검 HY 8001 중 어느 한 균주 또는 이들의 혼합균주인 것을 특징으로 하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 제 1항에 있어서, 상기 난황은 최대희석배율 1 : 3000 이상의 효소면역흡착법에 의한 항체역가를 갖춘 것을 특징으로 하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 제 1항에 있어서, 상기 난황은 마이크로타이터법에 의한 응집항체가가 1 : 500 이하인 것을 특징으로 하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 제 1항에 있어서, 상기 난황중의 항체량은 상기 식품 총중량의 0.25% 미만으로 함유되어 있음을 특징으로 하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 제 1항에 있어서, 상기 난황 중의 항체의 역가보존 및 물리적 안정성을 위하여 보호제로 1 중량% 의 소혈장 단백질과 5-15 중량% 설탕(sucrose)이 함유되어 있음을 특징으로 하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 제 3항에 있어서, 상기 난황은 최대희석배율 1 : 3000 이하의 효소면역흡착법에 의한 항체역가를 갖춘 것을 특징으로 하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 제 3항에 있어서, 상기 난황은 마이크로타이터법에 의한 응집항체가가 1 : 500 이하인 것을 특징으로 하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 제 3항에 있어서, 상기 난황중의 항체량은 상기 식품 총중량의 0.25% 미만으로 함유되어 있음을 특징으로 하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 제 3항에 있어서, 상기 난황 중의 항체의 역가보존 및 물리적 안정성을 위하여 보호제로 1 중량% 의 소혈장 단백질과 5-15 중량% 설탕(sucrose)이 함유되어 있음을 특징으로 하는 위염, 위궤양 및 십이지장궤양 예방 및 치료식품.
- 제 3항에 있어서, 상기 식품은 발효유, 아이스크림, 빵, 과자, 조제분유, 음료, 마가린, 버터, 치즈, 유아용 식품과 같은 일상적으로 섭취하는 일반식인 것을 특징으로 하는 위염, 위궤양, 십이지장궤양 예방 및 치료식품.
- 제 3항에 있어서, 상기 식품은 위 및 십이지장궤양 환자, 위 또는 십이지장 수술을 받은 환자, 위장장해를 수반하는 약물을 투여하는 환자와 같은 환자의 병원식 또는 경구수액인 것을 특징으로 하는 위염, 위궤양, 십이지장궤양 예방 및 치료식품.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990040387A KR100324441B1 (ko) | 1999-02-08 | 1999-09-20 | 위염, 위궤양, 십이지장궤양 예방을 위한 식품 |
US09/498,668 US6329002B1 (en) | 1999-02-08 | 2000-02-07 | Food for inhibiting infection and treating gastritis, gastric and duodenal ulcers |
US09/974,461 US6491956B2 (en) | 1999-02-08 | 2001-10-10 | Food containing active strains for inhibiting infection and treating gastritis, gastric and duodenal ulcers |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19990004234 | 1999-02-08 | ||
KR1019990004234 | 1999-02-08 | ||
KR1019990040387A KR100324441B1 (ko) | 1999-02-08 | 1999-09-20 | 위염, 위궤양, 십이지장궤양 예방을 위한 식품 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000056981A true KR20000056981A (ko) | 2000-09-15 |
KR100324441B1 KR100324441B1 (ko) | 2002-02-27 |
Family
ID=26634681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990040387A KR100324441B1 (ko) | 1999-02-08 | 1999-09-20 | 위염, 위궤양, 십이지장궤양 예방을 위한 식품 |
Country Status (2)
Country | Link |
---|---|
US (2) | US6329002B1 (ko) |
KR (1) | KR100324441B1 (ko) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020021545A (ko) * | 2000-09-15 | 2002-03-21 | 이은선 | 면역단백질이 강화된 난황액을 이용한 발효유, 우유,아이스크림 및 그 제조방법 |
JP2002322086A (ja) * | 2001-04-27 | 2002-11-08 | Morinaga Milk Ind Co Ltd | ヘリコバクター・ピロリ感染予防治療剤並びに感染予防治療用飲食品 |
KR100364198B1 (ko) * | 2000-06-09 | 2002-12-12 | 영농조합법인다한 | 헬리코박터 파이로리에 대한 개선된 lgY 생성의유도방법 및 이에 의해 제조된 계란 |
KR20020093410A (ko) * | 2001-06-08 | 2002-12-16 | (주)두솔 | 기능성 연두부 및 그 제조방법 |
KR20030012560A (ko) * | 2001-08-01 | 2003-02-12 | 주식회사 리앤조바이오텍 | 기능성 두유 및 그 제조방법 |
KR100375342B1 (ko) * | 2000-02-08 | 2003-03-08 | 주식회사 풀 무 원 | 위장 질환 개선을 위한 천연 항균물질 조성물 |
KR100403282B1 (ko) * | 2001-06-29 | 2003-10-30 | 주식회사 에그 바이오택 | 항-대장균 및 항-헬리코박터 피로리 혼합특수면역단백질함유 난황과 알로에분말, 녹차추출물분말및 들깨잎분말을 함유한 헬리코박터 피로리 성장억제식품조성물 및 상기 조성물을 함유한 요구르트 |
KR100424791B1 (ko) * | 2000-12-08 | 2004-03-30 | (주) 피엘바이오 | 헬리코박터 필로리의 활성을 억제하는 유산균 |
KR100424790B1 (ko) * | 2000-12-08 | 2004-03-30 | (주) 피엘바이오 | 헬리코박터 필로리의 활성을 억제하는 유산균 |
KR100435505B1 (ko) * | 2002-03-27 | 2004-06-10 | (주) 피엘바이오 | 김치에서 분리된 헬리코박터 필로리의 부착과성장억제성능 락토바실러스 플란타룸 |
KR100449597B1 (ko) * | 2000-12-08 | 2004-09-18 | (주) 피엘바이오 | 헬리코박터 필로리의 활성을 억제하는 유산균 |
KR100449599B1 (ko) * | 2000-12-08 | 2004-09-18 | (주) 피엘바이오 | 헬리코박터 필로리의 활성을 억제하는 유산균 |
KR100518263B1 (ko) * | 2002-11-21 | 2005-10-04 | 학교법인 한마학원 | 락토코쿠스 락티스 nk24 (kfcc 11315) 생균을유효성분으로 함유하는 것을 특징으로 하는 위장병 예방및 치료용 조성물 |
KR100729658B1 (ko) * | 2000-09-22 | 2007-06-18 | 농업회사법인 오보바이오 주식회사 | 헬리코박터 필로리 감염성 위질환의 예방과 치료를 위한새로운 치료법 개발과 고 특이성 항 헬리코박터 필로리면역글로블린 와이 |
KR100785666B1 (ko) * | 2001-08-01 | 2007-12-14 | 농업회사법인 오보바이오 주식회사 | 기능성 푸딩 및 그 제조방법 |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3430853B2 (ja) * | 1997-04-11 | 2003-07-28 | 株式会社ゲン・コーポレーション | 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤 |
KR100324441B1 (ko) * | 1999-02-08 | 2002-02-27 | 이은선 | 위염, 위궤양, 십이지장궤양 예방을 위한 식품 |
FR2809312B1 (fr) * | 2000-05-25 | 2002-07-12 | Gervais Danone Sa | Utilisation de l. casei dans des compositions immunostimulantes |
MY128159A (en) * | 2000-06-30 | 2007-01-31 | Wyeth Corp | Methods and composition for oral vaccination |
AU2002307448A1 (en) * | 2001-04-20 | 2002-11-05 | President And Fellows Of Harvard College | Methods and compositions for the modulation of biofilm formation |
FI20011403A (fi) * | 2001-06-29 | 2002-12-30 | Carbion Oy | Menetelmä ja koostumukset vatsan sairauksien hoitoon |
KR100436038B1 (ko) * | 2001-12-19 | 2004-06-12 | 씨제이 주식회사 | 비열처리 생식품의 제조방법 및 그로부터 수득되는 생식품 |
KR100449146B1 (ko) * | 2001-12-19 | 2004-09-18 | 씨제이 주식회사 | 헬리코박터 파이로리 및 식중독균 억제 효과를 갖는발효식품의 제조방법 및 그 제조방법에 의해 제조된발효식품 |
WO2003063886A1 (fr) * | 2002-01-28 | 2003-08-07 | Nisshin Pharma Inc. | Inhibiteur d'adhesion d'helicobacter pylori |
KR20040111506A (ko) * | 2002-04-12 | 2004-12-31 | 메이지 데어리스 코포레이션 | 헬리코박터 파일로리를 살균하는 치즈 첨가물 |
US20050180962A1 (en) * | 2003-01-30 | 2005-08-18 | Eyal Raz | Inactivated probiotic bacteria and methods of use thereof |
CA2448843A1 (fr) * | 2003-11-13 | 2005-05-13 | Bio-K Plus International Inc. | Effets de differents surnageants de bacteries lactiques de bio-k plus sur des lignees cellulaires endotheliales |
FR2876029B1 (fr) * | 2004-10-04 | 2008-11-14 | Oreal | Composition cosmetique et/ou dermatologique pour peaux sensibles. |
JP5112069B2 (ja) * | 2004-10-04 | 2013-01-09 | ロレアル | 敏感肌のための化粧品及び/または皮膚科組成物 |
WO2006106806A1 (ja) * | 2005-03-30 | 2006-10-12 | Kyowa Hakko Kogyo Co., Ltd. | 乾燥微生物の保存安定性向上方法 |
KR100661032B1 (ko) * | 2005-04-19 | 2006-12-22 | 주식회사한국야쿠르트 | 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물 |
FR2889057B1 (fr) * | 2005-08-01 | 2008-07-18 | Oreal | Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches |
CN101360512A (zh) * | 2005-08-19 | 2009-02-04 | 荷兰联合利华有限公司 | 包含益生菌微生物和抗体的食物产品 |
CN1940060B (zh) * | 2005-09-28 | 2010-05-05 | 曾浩洋 | 新颖嗜乳酸菌及其应用 |
FR2919501B1 (fr) * | 2007-08-02 | 2010-12-31 | Oreal | Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees |
FR2920305B1 (fr) * | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
ES2461791T3 (es) * | 2007-09-04 | 2014-05-21 | L'oréal | Utilización de una combinación de hesperidina y de un microorganismo para actuar sobre la función de barrera de la piel |
FR2920304B1 (fr) * | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
US8646243B2 (en) * | 2007-10-04 | 2014-02-11 | Medical Instill Technologies, Inc. | Apparatus for formulating and aseptically filling liquid products |
PL2219478T3 (pl) * | 2007-12-17 | 2017-10-31 | Newtricious Bv | Sposób wytwarzania funkcjonalnego produktu spożywczego na bazie żółtka jaja i produkty otrzymywane tym sposobem |
CN101411362B (zh) * | 2008-10-14 | 2012-05-30 | 大连韩伟企业集团有限公司 | 抗幽门螺杆菌蛋黄免疫球蛋白酸奶 |
FR2942719B1 (fr) * | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
JP2013505289A (ja) * | 2009-09-23 | 2013-02-14 | トーマス・ジュリアス・ボロディ | 腸管感染症の治療法 |
US7888062B1 (en) | 2010-02-01 | 2011-02-15 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US8445226B2 (en) * | 2010-02-01 | 2013-05-21 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
TWI401086B (zh) | 2010-07-20 | 2013-07-11 | Univ China Medical | 胚芽乳酸桿菌及其用途 |
CN102636641B (zh) * | 2012-03-26 | 2014-06-25 | 上海凯创生物技术有限公司 | 胃幽门螺旋杆菌乳胶法检测试剂盒及其制备工艺 |
TWI463986B (zh) | 2012-08-29 | 2014-12-11 | Univ China Medical | 胚芽乳酸桿菌cmu995菌株之新用途 |
US9737592B1 (en) | 2014-02-14 | 2017-08-22 | David Gordon Bermudes | Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11839633B2 (en) * | 2020-03-17 | 2023-12-12 | SVK Herbal Corporation | Composition and method of treating gastrointestinal disease with microbial and soy mixture |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3072353B2 (ja) | 1991-03-01 | 2000-07-31 | 太陽化学株式会社 | 胃炎,胃または十二指腸潰瘍予防食品 |
DE69219768T2 (de) * | 1992-07-06 | 1997-08-28 | Nestle Sa | Milchbakterien |
JP3430853B2 (ja) | 1997-04-11 | 2003-07-28 | 株式会社ゲン・コーポレーション | 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤 |
KR100324441B1 (ko) * | 1999-02-08 | 2002-02-27 | 이은선 | 위염, 위궤양, 십이지장궤양 예방을 위한 식품 |
-
1999
- 1999-09-20 KR KR1019990040387A patent/KR100324441B1/ko active IP Right Grant
-
2000
- 2000-02-07 US US09/498,668 patent/US6329002B1/en not_active Expired - Fee Related
-
2001
- 2001-10-10 US US09/974,461 patent/US6491956B2/en not_active Expired - Lifetime
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100375342B1 (ko) * | 2000-02-08 | 2003-03-08 | 주식회사 풀 무 원 | 위장 질환 개선을 위한 천연 항균물질 조성물 |
KR100364198B1 (ko) * | 2000-06-09 | 2002-12-12 | 영농조합법인다한 | 헬리코박터 파이로리에 대한 개선된 lgY 생성의유도방법 및 이에 의해 제조된 계란 |
KR20020021545A (ko) * | 2000-09-15 | 2002-03-21 | 이은선 | 면역단백질이 강화된 난황액을 이용한 발효유, 우유,아이스크림 및 그 제조방법 |
KR100729658B1 (ko) * | 2000-09-22 | 2007-06-18 | 농업회사법인 오보바이오 주식회사 | 헬리코박터 필로리 감염성 위질환의 예방과 치료를 위한새로운 치료법 개발과 고 특이성 항 헬리코박터 필로리면역글로블린 와이 |
KR100449597B1 (ko) * | 2000-12-08 | 2004-09-18 | (주) 피엘바이오 | 헬리코박터 필로리의 활성을 억제하는 유산균 |
KR100424791B1 (ko) * | 2000-12-08 | 2004-03-30 | (주) 피엘바이오 | 헬리코박터 필로리의 활성을 억제하는 유산균 |
KR100424790B1 (ko) * | 2000-12-08 | 2004-03-30 | (주) 피엘바이오 | 헬리코박터 필로리의 활성을 억제하는 유산균 |
KR100449599B1 (ko) * | 2000-12-08 | 2004-09-18 | (주) 피엘바이오 | 헬리코박터 필로리의 활성을 억제하는 유산균 |
JP2002322086A (ja) * | 2001-04-27 | 2002-11-08 | Morinaga Milk Ind Co Ltd | ヘリコバクター・ピロリ感染予防治療剤並びに感染予防治療用飲食品 |
KR20020093410A (ko) * | 2001-06-08 | 2002-12-16 | (주)두솔 | 기능성 연두부 및 그 제조방법 |
KR100403282B1 (ko) * | 2001-06-29 | 2003-10-30 | 주식회사 에그 바이오택 | 항-대장균 및 항-헬리코박터 피로리 혼합특수면역단백질함유 난황과 알로에분말, 녹차추출물분말및 들깨잎분말을 함유한 헬리코박터 피로리 성장억제식품조성물 및 상기 조성물을 함유한 요구르트 |
KR20030012560A (ko) * | 2001-08-01 | 2003-02-12 | 주식회사 리앤조바이오텍 | 기능성 두유 및 그 제조방법 |
KR100785666B1 (ko) * | 2001-08-01 | 2007-12-14 | 농업회사법인 오보바이오 주식회사 | 기능성 푸딩 및 그 제조방법 |
KR100435505B1 (ko) * | 2002-03-27 | 2004-06-10 | (주) 피엘바이오 | 김치에서 분리된 헬리코박터 필로리의 부착과성장억제성능 락토바실러스 플란타룸 |
KR100518263B1 (ko) * | 2002-11-21 | 2005-10-04 | 학교법인 한마학원 | 락토코쿠스 락티스 nk24 (kfcc 11315) 생균을유효성분으로 함유하는 것을 특징으로 하는 위장병 예방및 치료용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
US6491956B2 (en) | 2002-12-10 |
KR100324441B1 (ko) | 2002-02-27 |
US6329002B1 (en) | 2001-12-11 |
US20020037341A1 (en) | 2002-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100324441B1 (ko) | 위염, 위궤양, 십이지장궤양 예방을 위한 식품 | |
CA2234565C (en) | Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers | |
EP0508701B1 (en) | Probiotic | |
NO327205B1 (no) | Lactobacillus paracasei-stamme, sammensetning inneholdende en slik stamme samt anvendelser derav. | |
US5576300A (en) | Method for inhibition of human rotavirus infection | |
EP0454813B1 (en) | A casein fraction for therapeutic, prophylactic and/or diagnostic use in infections of the respiratory tract | |
JP4489315B2 (ja) | 抗ヘリコバクターピロリ抗体を含有する卵黄液を用いた発酵乳の製造方法 | |
US6506388B1 (en) | Immunomodulator, immunomodulator food | |
KR20010098578A (ko) | 헬리코박터 필로리의 정착에 대한 저해 작용을 갖는당단백질 | |
JP3072353B2 (ja) | 胃炎,胃または十二指腸潰瘍予防食品 | |
KR100646938B1 (ko) | 헬리코박터 필로리의 정착과 생육 활성을 저해하는락토바실루스 람노서스 아이디씨씨 3201 | |
KR100503570B1 (ko) | 면역증강, 항암 및 항균 활성을 갖는 신규한 페디오코커스펜토사세우스 erom101 | |
US5712250A (en) | Product for inhibition of human rotavirus infection | |
KR100415911B1 (ko) | 대장균 및 헬리코박터 피로리균에 대한 항-혼합균 공유 복합항체 면역단백질(IgY)을 보유한 계란생산방법 및 상기 생산방법으로 생산된 계란, 항-혼합균 공유 복합항체 면역단백질(IgY)을 함유한 요구르트 및 아이스크림 | |
EA016734B1 (ru) | СРЕДСТВА ДЛЯ СТИМУЛЯЦИИ ПРОДУЦИРОВАНИЯ IgA НА ОСНОВЕ БАКТЕРИЙ LACTOBACILLUS AMYLOVORUS И ШТАММ БАКТЕРИЙ LACTOBACILLUS AMYLOVORUS CP1750 FERM BP-10532 | |
KR100435829B1 (ko) | 수크라아제와 말타아제에 대한 난황항체의 생산방법 및이를 이용한 식이 탄수화물의 흡수 억제용 조성물 | |
KR102054800B1 (ko) | 베타카리오필렌을 함유하는 항헬리코박터 식품 조성물 | |
JPH03151853A (ja) | 抗体およびそれを有効成分とする整腸食品 | |
JP3255161B2 (ja) | ヘリコバクター・ピロリ定着阻害剤 | |
KR100476502B1 (ko) | 항-헬리코박터 필로리 고역가 항체 제조방법 및 이를함유하는 식품 | |
KR100573424B1 (ko) | 항 헬리코박터 파일로리 항체를 포함한 면역우유 및 그 생산방법 | |
KR100443080B1 (ko) | 콜레스테롤 저하능을 갖는 스트렙토코커스 페시움 균주 | |
JP3597784B2 (ja) | 消化性潰瘍抑制組成物及びそれを含有する飲食品 | |
KR100785666B1 (ko) | 기능성 푸딩 및 그 제조방법 | |
KR20020023521A (ko) | 헬리코박터 필로리 감염성 위질환의 예방과 치료를 위한새로운 치료법 개발과 고 특이성 항 헬리코박터 필로리면역글로블린 와이 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130107 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20140106 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20150106 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20160126 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20170109 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20180111 Year of fee payment: 17 |